Japanese multinational pharmaceutical company, with American and British roots, Takeda, is holding talks with India’s medicine regulator, the Drug Controller General of India (DCGI), for bringing its dengue vaccine to the country. Mahender Nayak, head of Asia Pacific, Takeda Pharmaceuticals, said that the company was discussing terms of regulatory approval...
India’s Glenmark Develops Novel Oncology Therapy
Mumbai-based Glenmark Pharmaceuticals announced that its subsidiary Glenmark Specialty received approval from the Indian drug regulator, Drug Controller General of India (DCGI), to conduct a Phase 1 clinical trial of its novel small molecule, GRC 54276. It also plans to file an Investigational New Drug program in the U.S. along...
India Approves Nasal Covid-19 Vaccine
The Drug Controller General of India authorized the country’s first nasal spray vaccine "under Restricted Use in Emergency Situations for ages 18 and above," marking a big step toward increasing the availability of needle-free vaccines around the world. Washington University St. Louis, which had created and developed the recombinant adenoviral...